Lopinavir and Ritonavir Oral Solution shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-07-24 · last update 2026-07-24
Manufacturers: AbbVie Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Kaletra, Oral Solution, 80 mg/1 mL; 20 mg/1 mL (NDC 0074-3956-46) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/24/2026 Updated 07/24/2026 Discontinued 07/24/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)